Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biocon 1
Bangalore, Karnataka, India
- Ownership
- Private
- Employees
- ~7500
- Development stage
- Other
01
Overview
Biocon is a leading global biopharmaceutical company with a robust pipeline of biosimilars and generics, globally commercialized insulins, and novel biologics; its clinical results have enabled regulatory approvals in markets such as the US, EU, and Japan, with rapid expansion in oncology, diabetes, and autoimmune indications
- Therapeutic areas
- HematologyImmunologyNephrologyEndocrinologyCardiovascularInfectious DiseasesOncology
- Modalities
- Small moleculeMonoclonal antibodyRecombinant proteinBiosimilarBiologicPeptideAntibody-drug conjugateSynthetic oligonucleotide
- Industry
- Biotech
02
Partnerships
Viatris (biosimilars)Mylan (biosimilars)Sandoz (biosimilars and immunology/oncology)Amylin Pharmaceuticals (peptide diabetes therapeutics)IATRICa (immunoconjugates)Optimer Pharmaceuticals (fidaxomicin API)Vaccinex (antibody platform + candidates BVX 10, BVX 20)Abraxis BioScience (GCSF biosimilar out-licensing)Serum Institute of India (vaccines and biologics)
Beyond the preview
Go deeper on Biocon 1.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biocon 1.